|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/52 | (2006.01) |
| A61K 9/08 | (2013.01) | ||
| A61K 31/7076 | (2006.01) | ||
| A61K 31/7076 | (2013.01) | ||
| A61P 27/06 | (2018.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 9/48 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61K 9/08 | (2006.01) | ||
| A61K 9/0048 | (2013.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61K 47/10 | (2013.01) | ||
| A61P 27/06 | (2006.01) | ||
| A61K 47/12 | (2013.01) | ||
| A61K 47/14 | (2013.01) | ||
| A61K 9/4866 | (2013.01) | ||
| A61K 9/4858 | (2013.01) | ||
| A61K 47/44 | (2013.01) | ||
| A61K 31/52 | (2013.01) |
| (11) | Number of the document | 3725317 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18883014.5 |
| Date of filing the European patent application | 2018-11-29 | |
| (97) | Date of publication of the European application | 2020-10-21 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/KR2018/014943 |
| Date | 2018-11-29 |
| (87) | Number | WO 2019/107964 |
| Date | 2019-06-06 |
| (30) | Number | Date | Country code |
| 20170161545 | 2017-11-29 | KR |
| (72) |
YANG, Jae Wook , KR
KIM, Jee Young , KR
LEE, Hyuk Woo , KR
PARK, Chong-Woo , KR
YU, Mi Ra , KR
LEE, Ji Youn , KR
PARK, Bo Mi , KR
|
| (73) |
Future Medicine Co., Ltd. ,
(Siheung-dong)
616 LH Pangyo Business Growth Center
54 Changup-ro
Sujeong-gu, Seongnam-si, Gyeonggi-do 13449,
KR
|
| (54) | PHARMACEUTICAL COMPOSITION COMPRISING ADENOSINE DERIVATIVE FOR PREVENTION AND TREATMENT OF RETINAL DISEASE OR OPTIC NERVE DISEASE |
| PHARMACEUTICAL COMPOSITION COMPRISING ADENOSINE DERIVATIVE FOR PREVENTION AND TREATMENT OF RETINAL DISEASE OR OPTIC NERVE DISEASE |